Goldman Sachs’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-9,000
| Closed | -$1.62M | – | 6950 |
|
|
2017
Q3 | $1.62M | Sell |
9,000
-9,600
| -52% | -$1.34M | ﹤0.01% | 4161 |
|
|
2017
Q2 | $1.93M | Buy |
18,600
+4,100
| +28% | +$335K | ﹤0.01% | 3871 |
|
|
2017
Q1 | $1.14M | Buy |
14,500
+11,300
| +353% | +$699K | ﹤0.01% | 4256 |
|
|
2016
Q4 | $143K | Sell |
3,200
-275,600
| -99% | -$13.5M | ﹤0.01% | 5969 |
|
|
2016
Q3 | $15.6M | Buy |
278,800
+269,000
| +2,745% | +$15M | ﹤0.01% | 2087 |
|
|
2016
Q2 | $490K | Sell |
9,800
-34,600
| -78% | -$1.7M | ﹤0.01% | 4871 |
|
|
2016
Q1 | $2.04M | Sell |
44,400
-3,800
| -8% | -$184K | ﹤0.01% | 3448 |
|
|
2015
Q4 | $2.97M | Sell |
48,200
-12,000
| -20% | -$845K | ﹤0.01% | 3288 |
|
|
2015
Q3 | $3.35M | Buy |
60,200
+22,200
| +58% | +$1.4M | ﹤0.01% | 3268 |
|
|
2015
Q2 | $2.32M | Buy |
38,000
+31,900
| +523% | +$1.82M | ﹤0.01% | 3696 |
|
|
2015
Q1 | $352K | Buy |
+6,100
| New | +$409K | ﹤0.01% | 5493 |
|
Goldman Sachs's KITE Position: Q4 2017 in Review
Goldman Sachs sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 806,480 shares — an estimated $145M sold.
Goldman Sachs first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $145M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Goldman Sachs reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Goldman Sachs sold 806,480 Kite Pharma, Inc. shares in Q4 2017, an estimated $145M.
- Goldman Sachs first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
- Goldman Sachs's Kite Pharma, Inc. position peaked at $145M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Goldman Sachs's 13F filing for Q4 2017, filed 14 Feb 2018.